{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:49:36Z","timestamp":1789523376831,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.amjms.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T23:45:07Z","timestamp":1636847107000},"page":"209-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Carotid Artery Pathology in Inflammatory Diseases"],"prefix":"10.1016","volume":"363","author":[{"given":"Tayana","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Lehker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2021.11.002_bib0001","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2021.11.002_bib0002","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","article-title":"Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?","volume":"46","author":"Van Doornum","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0003","first-page":"505","article-title":"Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study","volume":"59","author":"Provan","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0004","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2021.11.002_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2021.11.002_bib0006","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2021.11.002_bib0007","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1046\/j.1365-2168.1998.00779.x","article-title":"Metabolic response to severe injury","volume":"85","author":"Hill","year":"1998","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjms.2021.11.002_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0889-857X(05)70207-6","article-title":"Rheumatoid arthritis. From bench to bedside","volume":"27","author":"McInnes","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.amjms.2021.11.002_bib0009","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.1780270805","article-title":"Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years","volume":"27","author":"Pincus","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/kew440","article-title":"Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis","volume":"56","author":"Alemao","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2021.11.002_bib0011","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kex038","article-title":"Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries","volume":"56","author":"Crowson","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0012","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3899\/jrheum.171008","article-title":"Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC\/AHA Risk Calculator","volume":"46","author":"Wahlin","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11883-012-0306-4","article-title":"The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis","volume":"15","author":"Darabian","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.amjms.2021.11.002_bib0014","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurheartj\/ehq185","article-title":"Imaging of atherosclerosis: carotid intima-media thickness","volume":"31","author":"O'Leary","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0015","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/STROKEAHA.110.589754","article-title":"Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromso Study","volume":"42","author":"Mathiesen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.amjms.2021.11.002_bib0016","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1747-4949.2006.00068.x","article-title":"Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies","volume":"1","author":"Spence","year":"2006","journal-title":"Int J Stroke"},{"key":"10.1016\/j.amjms.2021.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2013.11.014","article-title":"Carotid intima-media thickness and plaque in cardiovascular risk assessment","volume":"7","author":"Naqvi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjms.2021.11.002_bib0018","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","article-title":"Cardiovascular risk factors in women with and without rheumatoid arthritis","volume":"50","author":"Solomon","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0019","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar428","article-title":"Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis","volume":"4","author":"Dessein","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.amjms.2021.11.002_bib0020","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0021","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/postgradmedj-2013-204715rep","article-title":"Republished: the association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"90","author":"Zhang","year":"2014","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874312901610010049","article-title":"Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: predictors of Plaque Occurrence and Progression Over 24 Weeks","volume":"10","author":"Pope","year":"2016","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0023","first-page":"S35","article-title":"Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE)","volume":"52","author":"Anand","year":"2000","journal-title":"Indian Heart J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0024","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-017-1422-x","article-title":"Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis","volume":"19","author":"Olah","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjms.2021.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects","volume":"48","author":"Del Rincon","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0026","first-page":"1717","article-title":"Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0027","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s00415-018-8885-9","article-title":"Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke\/transient ischemic attack","volume":"265","author":"Chen","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0028","first-page":"1599","article-title":"A novel marker relationship between carotid intima media thickness and disease activity score-28 in patients with rheumatoid arthritis: human endothelial cell-specific molecule-1","volume":"49","author":"Tuzcu","year":"2019","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.amjms.2021.11.002_bib0029","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/jch.12440","article-title":"Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?","volume":"16","author":"Afsar","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.amjms.2021.11.002_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003319713513492","article-title":"Endocan\u2013a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study","volume":"65","author":"Balta","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0031","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cca.2020.07.041","article-title":"Endocan: a novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases","volume":"509","author":"Bessa","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjms.2021.11.002_bib0032","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00296-010-1446-x","article-title":"Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.amjms.2021.11.002_bib0033","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0961203307085312","article-title":"Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting","volume":"17","author":"Telles","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.amjms.2021.11.002_bib0034","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar4489","article-title":"Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events","volume":"16","author":"Frerix","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjms.2021.11.002_bib0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.33590\/emjrheumatol\/10311928","article-title":"Stroke and systemic lupus erythematosus: a review","volume":"5","author":"Cavallaro","year":"2018","journal-title":"EMJ Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0036","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/ATVBAHA.109.198424","article-title":"Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis","volume":"30","author":"Tyrrell","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000362","volume":"7","author":"Ajeganova","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.amjms.2021.11.002_bib0038","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0003319715616240","article-title":"Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus","volume":"67","author":"Icli","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0039","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/acr.21841","article-title":"High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjms.2021.11.002_bib0040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.30380","article-title":"Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis","volume":"63","author":"Au","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13075-019-1877-z","article-title":"Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters","volume":"21","author":"Gamal","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjms.2021.11.002_bib0042","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2214\/ajr.143.4.821","article-title":"Arterial manifestations of Behcet disease","volume":"143","author":"Park","year":"1984","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0043","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.avsg.2006.12.004","article-title":"Major arterial involvement and review of Behcet's disease","volume":"21","author":"Alpagut","year":"2007","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.amjms.2021.11.002_bib0044","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/ijd.13324","article-title":"Extra-medial thickness of carotid artery in patients with Behcet's disease: evaluation of atherosclerotic vessel wall changes with a novel carotid artery ultrasound index","volume":"55","author":"Sereflican","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0045","first-page":"109","article-title":"Subclinical atherosclerosis in Beh\u00e7et's disease","volume":"27","author":"Hassan","year":"2012","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0046","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.semarthrit.2015.06.018","article-title":"Subclinical atherosclerosis in Behcet's disease: a systematic review and meta-analysis","volume":"45","author":"Merashli","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0047","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4070\/kcj.2017.0004","article-title":"Increased arterial stiffness in Behcet's disease: a systematic review and meta-analysis","volume":"47","author":"Upala","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0048","first-page":"129","article-title":"Assessment of endocan serum level in patients with Behcet disease: relation to disease activity and carotid intima media thickness","volume":"27","author":"Hassan","year":"2020","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2008.02936.x","article-title":"Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis","volume":"23","author":"Balci","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0050","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0051","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1468-3083.2009.03481.x","article-title":"Subclinical atherosclerosis in patients with chronic psoriasis: a potential association","volume":"24","author":"El-Mongy","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0052","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.atherosclerosis.2014.10.008","article-title":"Increased subclinical atherosclerosis in patients with chronic plaque psoriasis","volume":"237","author":"Evensen","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjms.2021.11.002_bib0053","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","article-title":"The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2021.11.002_bib0054","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality","volume":"145","author":"Prodanovich","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.12525","article-title":"Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease","volume":"169","author":"Balta","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0056","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjms.2021.11.002_bib0057","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2021.11.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/839135","article-title":"Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis","volume":"2014","author":"Gupta","year":"2014","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0059","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s40520-019-01137-2","article-title":"Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study","volume":"31","author":"Sun","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.amjms.2021.11.002_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ane.12208","article-title":"Association of uric acid and carotid artery disease in patients with ischemic stroke","volume":"130","author":"Kumral","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amjms.2021.11.002_bib0061","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.080646","article-title":"Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study","volume":"36","author":"Neogi","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0062","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.amjms.2021.11.002_bib0063","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000087713","article-title":"Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter","volume":"25","author":"Kang","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0064","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2021.11.002_bib0066","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.38920","article-title":"An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy","volume":"67","author":"Rao","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0067","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1759720X11436239","article-title":"Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity","volume":"4","author":"Marks","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.amjms.2021.11.002_bib0068","first-page":"2374","article-title":"Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement","volume":"31","author":"Hornung","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0069","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/rheumatology\/kep456","article-title":"Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment","volume":"49","author":"Ristic","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/DDDT.S166893","article-title":"Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.amjms.2021.11.002_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000467","article-title":"Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state","volume":"8","author":"McVeigh","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.amjms.2021.11.002_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment","volume":"18","author":"Hu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjms.2021.11.002_bib0073","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2021.11.002_bib0074","first-page":"e596","article-title":"ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2021.11.002_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/kem260","article-title":"Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review","volume":"47","author":"Metsios","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2021.11.002_bib0076","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12937-021-00663-y","article-title":"Diet intervention improves cardiovascular profile in patients with rheumatoid arthritis: results from the randomized controlled cross-over trial ADIRA","volume":"20","author":"Hulander","year":"2021","journal-title":"Nutr J"},{"key":"10.1016\/j.amjms.2021.11.002_bib0077","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.0000038754.39483.CD","article-title":"Unraveling pleiotropic effects of statins on plaque rupture","volume":"22","author":"Palinski","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0078","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0079","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1093\/rheumatology\/keaa190","article-title":"Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study","volume":"59","author":"Os","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjms.2021.11.002_bib0080","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.39114","article-title":"Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: the rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0081","first-page":"102","article-title":"Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins","volume":"25","author":"Gazi","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0082","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2021.11.002_bib0083","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.36740\/WLek202011117","article-title":"The effect of atorvastatinum in the treatment of patients with rheumatoid arthritis","volume":"73","author":"Shevchuk","year":"2020","journal-title":"Wiad Lek"},{"key":"10.1016\/j.amjms.2021.11.002_bib0084","first-page":"296","article-title":"Statin use and mortality in rheumatoid arthritis: an incident user cohort study","volume":"27","author":"Chhibber","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.amjms.2021.11.002_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.semarthrit.2020.11.010","article-title":"Statins and lower mortality in rheumatic diseases: an effect of immortal time bias?","volume":"51","author":"Abrahami","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.11.002_bib0086","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.amjms.2021.11.002_bib0087","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/ijmr.IJMR_640_19","article-title":"A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity","volume":"152","author":"Mostafa","year":"2020","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.amjms.2021.11.002_bib0088","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/art.40892","article-title":"A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis","volume":"71","author":"Kitas","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0089","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41584-020-0428-y","article-title":"Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis","volume":"16","author":"Semb","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.amjms.2021.11.002_bib0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/clpt.2011.35","article-title":"Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis","volume":"89","author":"Schmitt","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjms.2021.11.002_bib0091","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ehjcvp\/pvz033","article-title":"Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"6","author":"Hollan","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.amjms.2021.11.002_bib0092","article-title":"Rheumatoid arthritis, statin indication and lipid goals: analysis according to different recommendations","author":"Masson","year":"2021","journal-title":"Reumatol Clin"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921004055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921004055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:40:08Z","timestamp":1757702408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921004055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0002962921004055"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.11.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carotid Artery Pathology in Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}